| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00607094 |
| P698 | PubMed publication ID | 6411480 |
| P50 | author | Margareta Eriksson | Q77928448 |
| P2093 | author name string | L Paalzow | |
| P Bolme | |||
| T W Mariam | |||
| P2860 | cites work | Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis | Q30449443 |
| Drug metabolism in malnourished children: a study with antipyrine | Q34987130 | ||
| Drug Metabolism and Pharmacokinetics in Malnutrition | Q39725318 | ||
| Chloramphenicol and the Neonate — 1979 View | Q39806249 | ||
| The current status of chloramphenicol | Q39807500 | ||
| Central nervous system chloramphenicol concentration in premature infants | Q40618177 | ||
| The necessityfor monitoring chloramphenicol levels when treating neonatal meningitis | Q40848961 | ||
| Clinical pharmacology of two chloramphenicol preparations in children: sodium succinate (iv) and palmitate (oral) esters | Q40862240 | ||
| Chloramphenicol metabolism in children with protein-calorie malnutrition | Q41049162 | ||
| Chloramphenicol disposition in infants and children | Q41120473 | ||
| Pharmacokinetic study of antipyrine in malnourished children | Q41345877 | ||
| Drug kinetics in protein energy malnutrition | Q41415579 | ||
| Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery | Q42017833 | ||
| Effect of Plasma Protein Binding on Elimination of Warfarin | Q47868232 | ||
| Liver injury in protein-calorie malnutrition: an electron microscopic study | Q67289975 | ||
| Studies on the concentrations of chloramphenicol in the serum and cerebrospinal fluid of neonates, infants, and small children. Reciprocal reactions between chloramphenicol, penicillin and phenobarbitone | Q67541138 | ||
| Elimination of chloramphenicol and thiamphenicol in subjects with cirrhosis of the liver | Q69390147 | ||
| Steady state of chloramphenicol in malnourished children | Q70873175 | ||
| Chloramphenicol pharmacokinetics in infants and young children | Q71374894 | ||
| Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children | Q71483048 | ||
| Pharmacokinetic comparison of intravenous and oral chloramphenicol in patients with Haemophilus influenzae meningitis | Q72091997 | ||
| Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses | Q79299602 | ||
| P433 | issue | 6 | |
| P921 | main subject | Ethiopia | Q115 |
| chloramphenicol | Q274515 | ||
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 819-823 | |
| P577 | publication date | 1983-01-01 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status. | |
| P478 | volume | 24 |
| Q37765492 | A systematic review of pharmacokinetics studies in children with protein-energy malnutrition |
| Q35149016 | Antibiotics in severely malnourished children: systematic review of efficacy, safety and pharmacokinetics |
| Q40509022 | Classification and treatment of pneumonia |
| Q46315715 | Decreased chloramphenicol clearance in malnourished Ethiopian children |
| Q38756087 | Drug metabolism and pharmacokinetics in malnourished children |
| Q39604181 | Influences of diet and nutrition on clinical pharmacokinetics |
| Q38880229 | Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection |
| Q46839338 | Oral Absorption of Amoxicillin in Ethiopian Children with Respiratory Symptoms and Different Nutritional Status |
| Q37479752 | Pathophysiological changes that affect drug disposition in protein-energy malnourished children |
| Q34397610 | Pharmacokinetics of quinine in African children suffering from kwashiorkor |
| Q41913871 | Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor |
| Q38544086 | Theoretical pharmacokinetic drug alterations in pediatric celiac disease |
| Q47898726 | Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study. |
Search more.